According to a recent LinkedIn post from Daymark Health, the company is emphasizing its role in pursuing a “win-win-win” care model in oncology that aims to align payers, providers, patients, and families around supportive cancer care. The post cites its collaboration with Blue Cross & Blue Shield of Rhode Island and Brown University Health as an example of this approach in practice.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Daymark Health’s model is designed to create shared value across stakeholders, which could support payer adoption and provider engagement over time. For investors, the highlighted partnership may indicate traction in validating the company’s care model, potentially strengthening its position in value-based cancer care and enhancing prospects for further commercial relationships in similar markets.